Predicting pharmacodynamic effects through early drug discovery with artificial intelligence-physiologically based pharmacokinetic (AI-PBPK) modelling
A mechanism-based pharmacokinetic/pharmacodynamic (PK/PD) model links the concentration-time profile of a drug with its therapeutic effects based on the underlying biological or physiological processes. Clinical endpoints play a pivotal role in drug development. Despite the substantial time and effo...
Saved in:
Main Authors: | Keheng Wu (Author), Xue Li (Author), Zhou Zhou (Author), Youni Zhao (Author), Mei Su (Author), Zhuo Cheng (Author), Xinyi Wu (Author), Zhijun Huang (Author), Xiong Jin (Author), Jingxi Li (Author), Mengjun Zhang (Author), Jack Liu (Author), Bo Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development
by: Abdul Naveed Shaik, et al.
Published: (2019) -
Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery
by: Ri Han, et al.
Published: (2023) -
Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine
by: Dolores R. Serrano, et al.
Published: (2024) -
Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates
by: Lukas Kovar, et al.
Published: (2020) -
Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Brain Levels of Drug in Rat
by: Bárbara Sánchez-Dengra, et al.
Published: (2021)